Profil
Kfir Schreiber is the founder.
Mr. Schreiber is the founder of DeepCure, Inc. since 2018, holding the title of Chief Executive Officer & Director.
Mr. Schreiber is also the founder of Sapir Venture Partners LLC.
Mr. Schreiber's education history includes a graduate degree from the Massachusetts Institute of Technology conferred in 2018, a graduate degree from Tel-Aviv University conferred in 2015, and an undergraduate degree from The Open University of Israel conferred in 2006.
Aktive Positionen von Kfir Schreiber
| Unternehmen | Position | Beginn |
|---|---|---|
DeepCure, Inc.
DeepCure, Inc. BiotechnologyHealth Technology Engages in drug discovery activities and develops related software platform | Gründer | 01.09.2018 |
Sapir Venture Partners LLC
Sapir Venture Partners LLC Investment ManagersFinance Sapir Venture Partners invests in companies located in Israel and the United States, primarily in Boston and New York. The firm targets companies operating in the fields of deep-technology, biotech, science, and AI sectors. It participates in pre-seed capital requirements. | Berater | - |
Ausbildung von Kfir Schreiber
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Open University of Israel
The Open University of Israel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sapir Venture Partners LLC
Sapir Venture Partners LLC Investment ManagersFinance Sapir Venture Partners invests in companies located in Israel and the United States, primarily in Boston and New York. The firm targets companies operating in the fields of deep-technology, biotech, science, and AI sectors. It participates in pre-seed capital requirements. | Finance |
DeepCure, Inc.
DeepCure, Inc. BiotechnologyHealth Technology Engages in drug discovery activities and develops related software platform | Health Technology |
















